cloudfront

Report Detail



Pharma & HealthcareGlobal Ursodeoxycholic Acid Drug Product Market Growth 2019-2024

  • RnM2924970
  • |
  • 11 February, 2019
  • |
  • Global
  • |
  • 166 pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

Global Ursodeoxycholic Acid Drug Product Market Growth 2019-2024

Table of Contents

    2019-2024 Global Ursodeoxycholic Acid Drug Product Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Ursodeoxycholic Acid Drug Product Consumption 2014-2024
        • 2.1.2 Ursodeoxycholic Acid Drug Product Consumption CAGR by Region
      • 2.2 Ursodeoxycholic Acid Drug Product Segment by Type
        • 2.2.1 Capsule
        • 2.2.2 Tablet
      • 2.3 Ursodeoxycholic Acid Drug Product Consumption by Type
        • 2.3.1 Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Type (2014-2019)
        • 2.3.2 Global Ursodeoxycholic Acid Drug Product Revenue and Market Share by Type (2014-2019)
        • 2.3.3 Global Ursodeoxycholic Acid Drug Product Sale Price by Type (2014-2019)
      • 2.4 Ursodeoxycholic Acid Drug Product Segment by Application
        • 2.4.1 Gallstone
        • 2.4.2 Hepatopathy
        • 2.4.3 Biliary Disease
        • 2.4.4 Other
      • 2.5 Ursodeoxycholic Acid Drug Product Consumption by Application
        • 2.5.1 Global Ursodeoxycholic Acid Drug Product Consumption Market Share by Application (2014-2019)
        • 2.5.2 Global Ursodeoxycholic Acid Drug Product Value and Market Share by Application (2014-2019)
        • 2.5.3 Global Ursodeoxycholic Acid Drug Product Sale Price by Application (2014-2019)

      3 Global Ursodeoxycholic Acid Drug Product by Players

      • 3.1 Global Ursodeoxycholic Acid Drug Product Sales Market Share by Players
        • 3.1.1 Global Ursodeoxycholic Acid Drug Product Sales by Players (2017-2019)
        • 3.1.2 Global Ursodeoxycholic Acid Drug Product Sales Market Share by Players (2017-2019)
      • 3.2 Global Ursodeoxycholic Acid Drug Product Revenue Market Share by Players
        • 3.2.1 Global Ursodeoxycholic Acid Drug Product Revenue by Players (2017-2019)
        • 3.2.2 Global Ursodeoxycholic Acid Drug Product Revenue Market Share by Players (2017-2019)
      • 3.3 Global Ursodeoxycholic Acid Drug Product Sale Price by Players
      • 3.4 Global Ursodeoxycholic Acid Drug Product Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Ursodeoxycholic Acid Drug Product Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Ursodeoxycholic Acid Drug Product Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Ursodeoxycholic Acid Drug Product by Regions

      • 4.1 Ursodeoxycholic Acid Drug Product by Regions
        • 4.1.1 Global Ursodeoxycholic Acid Drug Product Consumption by Regions
        • 4.1.2 Global Ursodeoxycholic Acid Drug Product Value by Regions
      • 4.2 Americas Ursodeoxycholic Acid Drug Product Consumption Growth
      • 4.3 APAC Ursodeoxycholic Acid Drug Product Consumption Growth
      • 4.4 Europe Ursodeoxycholic Acid Drug Product Consumption Growth
      • 4.5 Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption Growth

      5 Americas

      • 5.1 Americas Ursodeoxycholic Acid Drug Product Consumption by Countries
        • 5.1.1 Americas Ursodeoxycholic Acid Drug Product Consumption by Countries (2014-2019)
        • 5.1.2 Americas Ursodeoxycholic Acid Drug Product Value by Countries (2014-2019)
      • 5.2 Americas Ursodeoxycholic Acid Drug Product Consumption by Type
      • 5.3 Americas Ursodeoxycholic Acid Drug Product Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Ursodeoxycholic Acid Drug Product Consumption by Countries
        • 6.1.1 APAC Ursodeoxycholic Acid Drug Product Consumption by Countries (2014-2019)
        • 6.1.2 APAC Ursodeoxycholic Acid Drug Product Value by Countries (2014-2019)
      • 6.2 APAC Ursodeoxycholic Acid Drug Product Consumption by Type
      • 6.3 APAC Ursodeoxycholic Acid Drug Product Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Ursodeoxycholic Acid Drug Product by Countries
        • 7.1.1 Europe Ursodeoxycholic Acid Drug Product Consumption by Countries (2014-2019)
        • 7.1.2 Europe Ursodeoxycholic Acid Drug Product Value by Countries (2014-2019)
      • 7.2 Europe Ursodeoxycholic Acid Drug Product Consumption by Type
      • 7.3 Europe Ursodeoxycholic Acid Drug Product Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Ursodeoxycholic Acid Drug Product by Countries
        • 8.1.1 Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption by Countries (2014-2019)
        • 8.1.2 Middle East & Africa Ursodeoxycholic Acid Drug Product Value by Countries (2014-2019)
      • 8.2 Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption by Type
      • 8.3 Middle East & Africa Ursodeoxycholic Acid Drug Product Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Channels
        • 10.1.2 Indirect Channels
      • 10.2 Ursodeoxycholic Acid Drug Product Distributors
      • 10.3 Ursodeoxycholic Acid Drug Product Customer

      11 Global Ursodeoxycholic Acid Drug Product Market Forecast

      • 11.1 Global Ursodeoxycholic Acid Drug Product Consumption Forecast (2019-2024)
      • 11.2 Global Ursodeoxycholic Acid Drug Product Forecast by Regions
        • 11.2.1 Global Ursodeoxycholic Acid Drug Product Forecast by Regions (2019-2024)
        • 11.2.2 Global Ursodeoxycholic Acid Drug Product Value Forecast by Regions (2019-2024)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Ursodeoxycholic Acid Drug Product Forecast by Type
      • 11.8 Global Ursodeoxycholic Acid Drug Product Forecast by Application

      12 Key Players Analysis

      • 12.1 Dr. Falk Pharma
        • 12.1.1 Company Details
        • 12.1.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.1.3 Dr. Falk Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.1.4 Main Business Overview
        • 12.1.5 Dr. Falk Pharma News
      • 12.2 Daewoong Pharmaceutical
        • 12.2.1 Company Details
        • 12.2.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.2.3 Daewoong Pharmaceutical Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.2.4 Main Business Overview
        • 12.2.5 Daewoong Pharmaceutical News
      • 12.3 Teva
        • 12.3.1 Company Details
        • 12.3.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.3.3 Teva Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.3.4 Main Business Overview
        • 12.3.5 Teva News
      • 12.4 Epic Pharma
        • 12.4.1 Company Details
        • 12.4.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.4.3 Epic Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.4.4 Main Business Overview
        • 12.4.5 Epic Pharma News
      • 12.5 Mitsubishi Tanabe Pharma
        • 12.5.1 Company Details
        • 12.5.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.5.3 Mitsubishi Tanabe Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.5.4 Main Business Overview
        • 12.5.5 Mitsubishi Tanabe Pharma News
      • 12.6 Lannett
        • 12.6.1 Company Details
        • 12.6.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.6.3 Lannett Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.6.4 Main Business Overview
        • 12.6.5 Lannett News
      • 12.7 Mylan
        • 12.7.1 Company Details
        • 12.7.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.7.3 Mylan Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.7.4 Main Business Overview
        • 12.7.5 Mylan News
      • 12.8 Bruschettini
        • 12.8.1 Company Details
        • 12.8.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.8.3 Bruschettini Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.8.4 Main Business Overview
        • 12.8.5 Bruschettini News
      • 12.9 Impax
        • 12.9.1 Company Details
        • 12.9.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.9.3 Impax Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.9.4 Main Business Overview
        • 12.9.5 Impax News
      • 12.10 Shanghai Pharma
        • 12.10.1 Company Details
        • 12.10.2 Ursodeoxycholic Acid Drug Product Product Offered
        • 12.10.3 Shanghai Pharma Ursodeoxycholic Acid Drug Product Sales, Revenue, Price and Gross Margin (2017-2019)
        • 12.10.4 Main Business Overview
        • 12.10.5 Shanghai Pharma News
      • 12.11 Grindeks

      13 Research Findings and Conclusion

      Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
      The classification of Ursodeoxycholic Acid Drug Product includes Capsule and Tablet. And the proportion of Capsule in 2017 is about 94.8%, and the proportion is in decreasing trend from 2013 to 2018, In China, the major product is tablet, and with low concentration UDCA, and the price is also low than other manufacturers. The major products of Dr. Falk Pharma, Daewoong Pharmaceutical, Teva are capsule.

      Ursodeoxycholic Acid Drug Product can be applied in Gallstone, Hepatopathy, Biliary Disease and Other. The most of Ursodeoxycholic Acid Drug Product is used in Gallstone, and the market share of that is about 36.5% in 2017.

      North America is the largest sales place, with a sales market share nearly 30% in 2017. Following North America, Europe is the second largest sales place with the Sales market share of 22.1%. Ursodeoxycholic Acid Drug Product market in Asia Pacific region is expected to exhibit the highest growth rate especially in the developing Asian countries like China & India.

      Dr. Falk Pharma, Daewoong Pharmaceutical, Teva, etc. are the global leading manufactures in the world. In the future, more generic manufacturers will enter into this industry.

      In North America, Epic Pharma is leading manufacturers, Teva, Lannett and Mylan are major suppliers of Ursodeoxycholic Acid Drug Product in USA market. In China, Dr. Falk Pharma is leading manufacturers, the market share is about 81% in 2017. In Japan, Mitsubishi Tanabe Pharma is leading manufacturers, the market share is about 52% in 2017. In Korea, Daewoong Pharmaceutical is leading manufacturers, the market share is about 86.1% in 2017

      According to this study, over the next five years the Ursodeoxycholic Acid Drug Product market will register a 11.9% CAGR in terms of revenue, the global market size will reach US$ 1900 million by 2024, from US$ 970 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Ursodeoxycholic Acid Drug Product business, shared in Chapter 3.

      This report presents a comprehensive overview, market shares, and growth opportunities of Ursodeoxycholic Acid Drug Product market by product type, application, key manufacturers and key regions and countries.

      This study considers the Ursodeoxycholic Acid Drug Product value and volume generated from the sales of the following segments:

      Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
      Capsule
      Tablet
      Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
      Gallstone
      Hepatopathy
      Biliary Disease
      Other

      This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
      Dr. Falk Pharma
      Daewoong Pharmaceutical
      Teva
      Epic Pharma
      Mitsubishi Tanabe Pharma
      Lannett
      Mylan
      Bruschettini
      Impax
      Shanghai Pharma
      Grindeks

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Ursodeoxycholic Acid Drug Product consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
      To understand the structure of Ursodeoxycholic Acid Drug Product market by identifying its various subsegments.
      Focuses on the key global Ursodeoxycholic Acid Drug Product manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Ursodeoxycholic Acid Drug Product with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Ursodeoxycholic Acid Drug Product submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.




      Summary:
      Get latest Market Research Reports on Ursodeoxycholic Acid Drug Product . Industry analysis & Market Report on Ursodeoxycholic Acid Drug Product is a syndicated market report, published as Global Ursodeoxycholic Acid Drug Product Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Ursodeoxycholic Acid Drug Product market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,660.00
      $5,490.00
      $7,320.00
      2,457.69
      3,686.54
      4,915.38
      3,367.93
      5,051.90
      6,735.86
      443,372.40
      665,058.60
      886,744.80
      242,707.04
      364,060.57
      485,414.09
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report